X4 Pharmaceuticals

XFOR

Börsenwert 321 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	1,07 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	949.162 $	-4 $	-1	-0 %
3	KCM 3 Kingdon Capital Management New York	443.331 $	-4 $	-1	-0 %
4	4 Vanguard Group Malvern, Pennsylvania	440.595 $	-151.551 $	-37.025	-14 %
5	5 BlackRock New York	340.534 $	-825.934 $	-201.782	-53 %
6	ACA 6 Acorn Capital Advisors New York	292.087 $	-368.216 $	-89.958	-37 %
7	7 GSA Capital Partners London, United Kingdom	252.000 $	+543.266 $	+132.724	Neu
8	8 UBS Group Zurich, Switzerland	208.922 $	-237.189 $	-57.947	-35 %
9	9 Jane Street New York	184.954 $	+398.448 $	+97.344	Neu
10	10 Bank of America Charlotte, North Carolina	152.600 $	+318.197 $	+77.738	+3.015 %
11	11 UBS O'Connor Chicago, Illinois	152.000 $	+292.991 $	+71.580	+850 %
12	12 Millennium Management New York	148.316 $	+284.215 $	+69.436	+805 %
13	13 Pale Fire Capital SE Prague, Czech Republic	114.097 $	-31.902 $	-7.794	-11 %
14	14 Geode Capital Management Boston, Massachusetts	93.398 $	-292.705 $	-71.510	-59 %
15	15 Squarepoint New York	74.066 $	+159.561 $	+38.982	Neu
16	16 Susquehanna International Group Bala Cynwyd, Pennsylvania	66.160 $	-91.106 $	-22.258	-39 %
17	17 AQR Capital Management Greenwich, Connecticut	50.125 $	+96.121 $	+23.483	+810 %
18	18 Point72 Asset Management Stamford, Connecticut	41.167 $	–	–	–
19	19 Goldman Sachs New York	35.842 $	+39.847 $	+9.735	+107 %
20	20 Renaissance Technologies New York	32.995 $	+68.340 $	+16.696	+2.492 %
21	21 State Street Boston, Massachusetts	29.515 $	-353.251 $	-86.302	-85 %
22	22 Virtu Financial New York	24.000 $	+42.336 $	+10.343	+461 %
23	23 Schonfeld Strategic Advisors New York	21.395 $	+327 $	+80	+0,7 %
24	24 Morgan Stanley New York	20.755 $	-33.057 $	-8.076	-43 %
25	25 HRT Financial New York	20.000 $	+38.472 $	+9.399	+818 %

X4 Pharmaceuticals XFOR Börsenwert 321 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 321 Mio. $